Sumitomo Mitsui DS Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$397K Buy
1,751
+480
+38% +$85.5K ﹤0.01% 697
2026
Q1
$219K Hold
1,271
﹤0.01% 742
2025
Q4
$254K Buy
+1,271
New +$231K ﹤0.01% 728
2025
Q2
Sell
-1,343
Closed -$202K 764
2025
Q1
$202K Sell
1,343
-4,608
-77% -$773K ﹤0.01% 751
2024
Q4
$1.1M Buy
5,951
+133
+2% +$25.6K 0.01% 612
2024
Q3
$1.15M Buy
5,818
+141
+2% +$29.3K 0.01% 603
2024
Q2
$1.17M Buy
5,677
+1,386
+32% +$314K 0.01% 574
2024
Q1
$1.16M Buy
4,291
+46
+1% +$11K 0.01% 566
2023
Q4
$1M Hold
4,245
0.01% 610
2023
Q3
$832K Buy
4,245
+79
+2% +$16.2K 0.01% 599
2023
Q2
$876K Buy
4,166
+26
+0.6% +$5.17K 0.01% 591
2023
Q1
$836K Buy
4,140
+50
+1% +$11.3K 0.02% 584
2022
Q4
$891K Buy
4,090
+48
+1% +$10.5K 0.02% 545
2022
Q3
$795K Buy
4,042
+921
+30% +$199K 0.02% 545
2022
Q2
$668K Buy
3,121
+50
+2% +$12.2K 0.02% 578
2022
Q1
$872K Sell
3,071
-461
-13% -$142K 0.02% 551
2021
Q4
$1.33M Buy
3,532
+465
+15% +$181K 0.03% 458
2021
Q3
$1.26M Sell
3,067
-20
-0.6% -$8.31K 0.03% 443
2021
Q2
$1.14M Buy
+3,087
New +$1.03M 0.03% 469

Other funds holding CRL

Sumitomo Mitsui DS Asset Management's CRL Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management increased its Charles River Laboratories (CRL) stake by 38% in Q2 2026, buying an estimated $85.5K and bringing the position to 1,751 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Sumitomo Mitsui DS Asset Management first reported a position in CRL in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.33M in Q4 2021. 125 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management held 1,751 shares of Charles River Laboratories worth $397K as of Q2 2026.
  • Sumitomo Mitsui DS Asset Management bought 480 Charles River Laboratories shares in Q2 2026, an estimated $85.5K.
  • Charles River Laboratories made up ﹤0.01% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #697 holding.
  • Sumitomo Mitsui DS Asset Management first reported a position in Charles River Laboratories in Q2 2021 and has held it in 19 quarters since.
  • Sumitomo Mitsui DS Asset Management's Charles River Laboratories position peaked at $1.33M in Q4 2021.
  • 125 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.